Up a level |
Recka, Martin and Luft, Alexander and Bondarenko, Igor and Shevnia, Serhii and Trukhin, Dmytro and Kovalenko, Nadezhda V. and Vacharadze, Kakha and Andrea, Fülöp and Hontsa, Anatoliy and Choi, Jihye and Shin, Donghoon (2020) A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer. Lung Cancer, V. 146. pp. 12-18. ISSN 0169-5002